Sun Pharmaceutical P/B Ratio

Current P/B Ratio
5.35
High Valuation
Very High - Significant premium, high growth expectations or speculative

Sun Pharmaceutical (SUNPHARMA) P/B ratio is 5.35 (High), book value per share ₹3495.00 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Explore SUNPHARMA fundamental worth to estimate fundamental worth using multiple valuation models.

Current Valuation Metrics

P/B Ratio 5.35
Current Price ₹1837.30
Book Value/Share ₹3495.00
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹83,880 Cr
Share Capital ₹240 Cr
Reserves & Surplus ₹83,330 Cr
Outstanding Shares 240,000,000
Book Value per Share ₹3495.00

Valuation Signal

Signal Overvalued
Historical Avg 0.55
Historical Range 0.47 - 0.67
Percentile 100.0%

Sector Context

Sector Average -0.01
Sector Median 0.62
Sector Rank #11 of 50
Sector Percentile 22.0%

SUNPHARMA P/B Ratio — Valuation Insights & Book Value Analysis

Sun Pharmaceutical price-to-book ratio interpretation, valuation status and historical context — current P/B 5.35 (High). Read SUNPHARMA dividend yield for the complete payout history and dividend yield track record.

  • Stock appears overvalued with PB of 5.35, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 872.7% above historical average
  • Trading at premium to sector average PB of -0.01

Sun Pharmaceutical P/B Ratio Historical Trend

SUNPHARMA annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see SUNPHARMA screener.

SUNPHARMA Historical P/B Ratio — Book Value Per Share & Year-End Price

Sun Pharmaceutical annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 0.53 ₹3495.0 ₹1837.30 ₹83,880 Low
2025 0.57 ₹3020.25 ₹1719.70 ₹72,486 Low
2024 0.67 ₹2796.92 ₹1886.35 ₹67,126 Low
2023 0.51 ₹2471.5 ₹1259.45 ₹59,316 Low
2022 0.47 ₹2127.75 ₹1001.40 ₹51,066 Low

SUNPHARMA vs Healthcare Peers — P/B Ratio Comparison

Sun Pharmaceutical P/B 5.35 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.

Sector Average
-0.01
Sector Median
0.62
Lowest P/B
-6.55
Highest P/B
1.09
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Parmax Pharma PARMAX -6.55 ₹46 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.0 ₹65 Low
Krebs Biochemicals & Ind… KREBSBIO -0.82 ₹129 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.21 ₹50 Low
Triochem Products TRIPR 0.04 ₹0 Low